Conferences

February 27, 2025

Learn how real-world axi-cel (Yescarta) outcomes compare to clinical trial data for people with relapsed/refractory large B-cell lymphoma.

February 18, 2025

If CAR T-cell therapy does not work, how effective are bispecific antibodies for people with large B-cell lymphoma? Learn answers from a recent study.

February 10, 2025

Explore side effects of bispecific antibodies for myeloma and B-cell lymphoma treatment, comparing brands on CRS, ICANS, and IEC-HS severity.

January 31, 2025

If blood cancer patients are referred to receive CAR T-cell therapy, what barriers are keeping them from receiving it? Learn answers in this article.

December 23, 2024

CAR T-cell therapy's long-term effects, patient-reported outcomes, and infection management strategies from ASH 2024. Expert insights from leading oncologists.

December 17, 2024

ASH 2024: bendamustine lymphodepletion before CAR T-cell therapy in aggressive lymphomas leads to fewer side effects while maintaining survival benefits.

December 10, 2024

Read research highlights from the ASH 2024 conference how certain lifestyle choices affect blood cancers.

December 10, 2024

Discover the board's selection of best abstracts at the 66th annual ASH conference.

December 08, 2024

Read about some of today’s DLBCL research topics presented at the ASH 2024 conference.

December 02, 2024

The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in DLBCL research.